Calcimimetic | List of Frontiers open access articles

Systematic Review

Published on 13 Aug 2025

Exploring global calcimimetics research trends: a systematic and thematic review of Web of Science and Scopus databases from 1997 to 2024

in Clinical Research in Nephrology

Riad Abdelrahman
Taha H. Musa
Chiamaka Linda Mgbechidinma
Eltieb Omer Ahmed

Frontiers in Nephrology

doi 10.3389/fneph.2025.1617466

3,066 views
1 citation

Case Report

Published on 21 Dec 2018

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism

in Bone Research

Giulia Di Dalmazi
Cesidio Giuliani
Giorgio Napolitano

Frontiers in Endocrinology

doi 10.3389/fendo.2018.00777

6,222 views
8 citations

Case Report

Published on 07 Jan 2025

Case report: Prolonged and severe hungry bone syndrome after parathyroidectomy in X-linked hypophosphatemia

in Bone Research

Giulia Puliani
Valeria Hasenmajer
Matteo Spaziani
Federico Frusone
Chiara Tarantino
Francesco Angelini
Ludovica Vincenzi
Riccardo Lubrano
Alessia Marcellino
Marco Biffoni

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1496386

4,581 views
1 citation

Mini Review

Published on 31 Jan 2022

Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report

in Cancer Endocrinology

Abdallah Roukain
Heba Alwan
Massimo Bongiovanni
Gerasimos P. Sykiotis
Peter A. Kopp

Frontiers in Endocrinology

doi 10.3389/fendo.2021.794988

11,825 views
16 citations

Original Research

Published on 06 Jul 2022

Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study

in Nephrology

Katharina Dörr
Sebastian Hödlmoser
Michael Kammer
Roman Reindl-Schwaighofer
Matthias Lorenz
Bianca Reiskopf
Rahel Jagoditsch
Rodrig Marculescu
Rainer Oberbauer

Frontiers in Medicine

doi 10.3389/fmed.2022.948177

3,470 views
5 citations

Original Research

Published on 24 Aug 2018

Activation of the Calcium-Sensing Receptor Corrects the Impaired Mitochondrial Energy Status Observed in Renal Polycystin-1 Knockdown Cells Modeling Autosomal Dominant Polycystic Kidney Disease

in Cellular Biochemistry

Annarita Di Mise
Marianna Ranieri
Mariangela Centrone
Maria Venneri
Grazia Tamma
Daniela Valenti
Giovanna Valenti

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2018.00077

6,912 views
21 citations

Original Research

Published on 02 Dec 2022

Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report

in Bone Research

Yuichi Takashi
Kyoko Toyokawa
Naoki Oda
Yoshimi Muta
Hisashi Yokomizo
Seiji Fukumoto
Daiji Kawanami

Frontiers in Endocrinology

doi 10.3389/fendo.2022.1004624

5,684 views
6 citations

Original Research

Published on 20 Apr 2023

The calcium-sensing receptor modulates the prostaglandin E2 pathway in intestinal inflammation

in Experimental Pharmacology and Drug Discovery

Valeriya Gushchina
Nadja Kupper
Michael Schwarzkopf
Gitta Frisch
Karina Piatek
Cornelia Aigner
Alexandra Michel
Hemma Schueffl
Luca Iamartino
Taha Elajnaf

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1151144

4,960 views
3 citations

Original Research

Published on 06 Aug 2024

Short-term therapy with R568 ameliorated secondary hyperparathyroidism but does not prevent aortic valve calcification in uremic rats

in Cardionephrology

Asmahan Abu-Snieneh
Irina Gurt
Suzan Abedat
Chaim Lotan
Michael Glikson
Mony Shuvy

Frontiers in Nephrology

doi 10.3389/fneph.2024.1385705

2,155 views

Articles

Exploring global calcimimetics research trends: a systematic and thematic review of Web of Science and Scopus databases from 1997 to 2024

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism

Case report: Prolonged and severe hungry bone syndrome after parathyroidectomy in X-linked hypophosphatemia

Denosumab for the Treatment of Hypercalcemia in a Patient With Parathyroid Carcinoma: A Case Report

Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study

Activation of the Calcium-Sensing Receptor Corrects the Impaired Mitochondrial Energy Status Observed in Renal Polycystin-1 Knockdown Cells Modeling Autosomal Dominant Polycystic Kidney Disease

Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report

The calcium-sensing receptor modulates the prostaglandin E2 pathway in intestinal inflammation

Short-term therapy with R568 ameliorated secondary hyperparathyroidism but does not prevent aortic valve calcification in uremic rats